DR. HUAMIN HENRY LI MD PHD NPI 1396733291

NPI Details

DR. Huamin Henry Li, MD, PHD is an allergy allergy immunology in Wheaton, MD with 38 years of experience. The provider is a physician who specializes in the diagnosis, treatment, and management of allergies. Source: National Uniform Claim Committee DR. Huamin Henry Li, MD, PHD NPI is 1396733291. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

11002 VEIRS MILL RD
SUITE 414
WHEATON, MD
ZIP 20902-521
Phone: (301) 962-5800
Fax: (301) 962-9585

The NPI 1396733291 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, omalizumab, 5 mg (HCPCS:J2357)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
• Injection, immune globulin (bivigam), 500 mg (HCPCS:J1556)
• Professional service for preparation and provision of 1 or more antigens (HCPCS:95165)
• Test for allergy using allergenic extract (HCPCS:95004)
• Professional service for multiple injections of allergen (HCPCS:95117)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Administration and interpretation of patient-focused health risk assessment (HCPCS:96160)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Measurement of neutralizing antibody to severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:86409)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Flow cytometry technique for dna or cell analysis, 16 or more markers (HCPCS:88189)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:M0220)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0004)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Test to measure expiratory airflow and volume (HCPCS:94010)
• Injection, tixagevimab and cilgavimab, for the pre-exposure prophylaxis only, for certain adults and pediatric individuals (12 years of age and older weighing at least 40kg) with no known sars-cov-2 exposure, who either have moderate to severely compromise (HCPCS:Q0220)

The enumeration date for this NPI number is 10/13/2005 and was last updated on 10/23/2007.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.